Health

Results: 1753-1764 of 7451

BioArctic to initiate next cohorts in exidavnemab Phase 2a study after positive safety review

Phase 3 Data for Incyte’s Retifanlimab (Zynyz®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet

Silence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia Vera

GlobeNewswire associated0

First of Its Kind in the Region: KFSHRC Successfully Performs Endoscopic Sleeve Gastroplasty on Kidney Transplant Patient

PR Newswire associated0

Volta Labs Expands Long-Read Sequencing Capabilities with Automated Oxford Nanopore Library Prep App on Callisto™

PR Newswire associated0

LabConnect Selects Deloitte to Streamline Financial and Business Operations

PR Newswire associated0

European Commission Grants Orphan Drug Designation to Florbetaben (18F) for Diagnosis of ATTR Amyloidosis

Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies

Chancellor invests in Britain’s renewal with up to 4 million additional NHS tests and procedures over the next five years

HOYA Vision Care Unveils Updates from the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting

Professor Lee Hae-young during the ESH 2025 symposium in Milan, Italy (Photo: Sky Labs)

Sky Labs at Forefront of Cuffless Blood Pressure Monitoring

ZINZINO AB (PUBL.): Zinzino announces Philippines as next step in its global expansion